Manerix

Moclobemide, the active ingredient in Manerix, is a monoamine oxidase inhibitor presented as an oral tablet for oral use. It treats major depressive disorder and is prescribed for adults who require a reversible MAO‑A inhibitor.

GNH USA supplies Manerix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclobemide is used within the antidepressant and anxiety‑disorder therapeutic area to improve mood and reduce depressive or anxious symptoms. - Major depressive disorder: alleviates core depressive symptoms and improves functional status. - Social anxiety disorder: reduces excessive fear and avoidance in social situations. - Persistent depressive disorder (dysthymia): helps sustain mood stability over long periods.

Moclobemide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient tension‑type headaches. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation, especially on standing. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Hypertensive crisis: sudden high blood pressure, often linked to tyramine intake. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities. - Severe liver injury: jaundice, elevated liver enzymes. - Agranulocytosis: marked reduction in white blood cells. - Psychosis: emergence of hallucinations or delusional thoughts. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks. - Hepatic function: assess liver enzymes prior to and during treatment. - Blood pressure: monitor regularly, especially when dietary tyramine is consumed. - Tyramine restriction: advise patients to avoid aged cheeses, cured meats, and fermented products. - Psychiatric history: screen for bipolar disorder or suicidal ideation. - Drug interaction review: verify concomitant medications that may potentiate MAO inhibition. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moclobemide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Tyramine‑rich foods: risk of hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Serotonin‑norepinephrine reuptake inhibitors (SNRIs): increased serotonergic activity. - Tricyclic antidepressants: additive MAO inhibition. - Linezolid or methylene blue: potent MAO inhibition.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened bleeding risk. - Antihypertensives: possible additive blood pressure lowering. - Carbamazepine: may reduce moclobemide plasma levels. - Alcohol: may exacerbate central nervous system depression. - Fluoxetine (if not avoided): moderate increase in serotonergic effects.